SEI Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2M Buy
223,243
+113,776
+104% +$1.02M ﹤0.01% 1651
2025
Q1
$821K Buy
109,467
+52,277
+91% +$392K ﹤0.01% 1983
2024
Q4
$430K Buy
57,190
+1,537
+3% +$11.6K ﹤0.01% 2235
2024
Q3
$423K Buy
55,653
+13,806
+33% +$105K ﹤0.01% 2238
2024
Q2
$259K Sell
41,847
-385
-0.9% -$2.38K ﹤0.01% 2391
2024
Q1
$215K Buy
42,232
+3,070
+8% +$15.6K ﹤0.01% 2408
2023
Q4
$235K Buy
39,162
+1,156
+3% +$6.93K ﹤0.01% 2399
2023
Q3
$269K Buy
38,006
+11,011
+41% +$78K ﹤0.01% 2340
2023
Q2
$190K Sell
26,995
-16,509
-38% -$116K ﹤0.01% 2486
2023
Q1
$363K Sell
43,504
-28,906
-40% -$241K ﹤0.01% 2260
2022
Q4
$831K Buy
72,410
+46,227
+177% +$531K ﹤0.01% 1830
2022
Q3
$330K Sell
26,183
-3,233
-11% -$40.7K ﹤0.01% 2267
2022
Q2
$311K Sell
29,416
-49,237
-63% -$521K ﹤0.01% 2305
2022
Q1
$1.28M Buy
78,653
+42,925
+120% +$698K ﹤0.01% 1725
2021
Q4
$495K Sell
35,728
-44,405
-55% -$615K ﹤0.01% 2108
2021
Q3
$1.15M Sell
80,133
-38,604
-33% -$554K ﹤0.01% 1733
2021
Q2
$1.88M Buy
+118,737
New +$1.88M ﹤0.01% 1541
2020
Q3
Sell
-94,898
Closed -$452K 2409
2020
Q2
$452K Buy
+94,898
New +$452K ﹤0.01% 1900
2019
Q2
Sell
-59,358
Closed -$483K 2416
2019
Q1
$483K Sell
59,358
-16,472
-22% -$134K ﹤0.01% 1907
2018
Q4
$612K Buy
+75,830
New +$612K ﹤0.01% 1696
2018
Q3
Sell
-588
Closed -$4K 2561
2018
Q2
$4K Hold
588
﹤0.01% 3186
2018
Q1
$3K Hold
588
﹤0.01% 3145
2017
Q4
$3K Hold
588
﹤0.01% 3022
2017
Q3
$3K Buy
588
+146
+33% +$745 ﹤0.01% 2909
2017
Q2
$2K Hold
442
﹤0.01% 2854
2017
Q1
$4K Hold
442
﹤0.01% 2605
2016
Q4
$3K Hold
442
﹤0.01% 2652
2016
Q3
$2K Hold
442
﹤0.01% 2633
2016
Q2
$1K Buy
+442
New +$1K ﹤0.01% 2525
2015
Q4
Sell
-27,734
Closed -$316K 2528
2015
Q3
$316K Buy
+27,734
New +$316K ﹤0.01% 1458